Single answer
Is AtriCure Inc (ATRC) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $0.99 or -1.15%
(In 11 weeks 5 days 18 hours 34 minutes and 10 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for AtriCure Inc is $50.67, which is $19.48 (62.46%) above the current price today's price.
Low target: $44.00 | High target: $55.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
AtriCure Inc develops manufactures and sells devices for the surgical ablation of cardiac tissue and systems and intercostal nerves to medical centers in the United States Europe Asia and internationally The company offers Isolator Synergy Clamps a singleuse disposable radio frequency products multifunctional pens and linear ablation devices such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias perform temporary cardiac pacing sensing and stimulation and ablate cardiac tissue with the same device and the Coolrail device which enable users to make longer linear lines of ablation It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths EPiSense Guided Coagulation System a singleuse disposable device used for the treatment of symptomatic drugrefractory and longstanding persistent atrial fibrillation AtriClip System an implantable device coupled to a singleuse disposable applier and LARIAT System a suturebased solution for softtissue closure compatible with a range of anatomical shapes In addition the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation Glidepath guides for placement of clamps Subtle Cannulas to support access for EPiSense catheters and various reusable cardiac surgery instruments which are used during surgical procedures for repair or replacement of certain heart valves It markets and sells its products through independent distributors and direct sales personnel The company was incorporated in 2000 and is headquartered in Mason Ohio
Website: https://www.atricure.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.13. Cash flow to debt ratio: 0.65. Net profit margin: -2.14%. Inflation risk score: low (0.45/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for AtriCure Inc is $21M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On AtriCure Inc, 2016-02-26 had a stock price of $17.00. If you invested back then, your return now would be a profit of $14.19 per share or 83.47%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.